Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (631-640 of 776) with videos related to

Pageof 78
Sort By:
Alzheimer'S Research & Therapy|March 28, 2023
Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individualsCorinne Pettigrew, Jurijs Nazarovs, Anja Soldan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2026
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectoriesRodrigo Cánovas, Christopher J Fowler, Azadeh Feizpour, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2012
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's diseaseAlan Rembach, James D Doecke, Blaine R Roberts, et al.
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 23, 2019
Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's diseaseSaori Hata, Chiori Omori, Ayano Kimura, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2013
Intensity of human prion disease surveillance predicts observed disease incidenceGenevieve M J A Klug, Handan Wand, Marion Simpson, et al.
Neurobiology of Disease|June 8, 2022
Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-βMarcela Cespedes, Kelly R Jacobs, Paul Maruff, et al.
Cell|September 7, 2010
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseJames A Duce, Andrew Tsatsanis, Michael A Cater, et al.
Pageof 78

Showing results (631-640 of 776) with videos related to

Sort By:
Pageof 78
Alzheimer'S Research & Therapy|March 28, 2023
Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individualsCorinne Pettigrew, Jurijs Nazarovs, Anja Soldan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2026
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectoriesRodrigo Cánovas, Christopher J Fowler, Azadeh Feizpour, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2012
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's diseaseAlan Rembach, James D Doecke, Blaine R Roberts, et al.
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 23, 2019
Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's diseaseSaori Hata, Chiori Omori, Ayano Kimura, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2013
Intensity of human prion disease surveillance predicts observed disease incidenceGenevieve M J A Klug, Handan Wand, Marion Simpson, et al.
Neurobiology of Disease|June 8, 2022
Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-βMarcela Cespedes, Kelly R Jacobs, Paul Maruff, et al.
Cell|September 7, 2010
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseJames A Duce, Andrew Tsatsanis, Michael A Cater, et al.
Pageof 78